EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Persistent SARS‐CoV ‐2 infection in patients seemingly recovered from COVID ‐19

Rossana Bussani, Lorena Zentilin, Ricardo Correa, Andrea Colliva, Furio Silvestri, Serena Zacchigna, Chiara Collesi, Mauro Giacca iD

The Journal of Pathology · 2023

DOI: 10.1002/path.6035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, 2023. Verfasst von Rossana Bussani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, British Heart Foundation, KCL.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS‐CoV‐2 infection is clinically heterogeneous, ranging from asymptomatic to deadly. A few patients with COVID‐19 appear to recover from acute viral infection but nevertheless progress in their disease and eventually die, despite persistent negativity at molecular tests for SARS‐CoV‐2 RNA. Here, we performed post‐mortem analyses in 27 consecutive patients who had apparently recovered from COVID‐19 but had progressively worsened in their clinical conditions despite repeated viral negativity in nasopharyngeal swabs or bronchioalveolar lavage for 11–300 consecutive days (average: 105.5 days). Three of these patients remained PCR‐negative for over 9 months. Post‐mortem analysis revealed evidence of diffuse or focal interstitial pneumonia in 23/27 (81%) patients, accompanied by extensive fibrotic substitution in 13 cases (47%). Despite apparent virological remission, lung pathology was similar to that observed in acute COVID‐19 individuals, including micro‐ and macro‐vascular thrombosis (67% of cases), vasculitis (24%), squamous metaplasia of the respiratory epithelium (30%), frequent cytological abnormalities and syncytia (67%), and the presence of dysmorphic features in the bronchial cartilage (44%). Consistent with molecular test negativity, SARS‐CoV‐2 antigens were not detected in the respiratory epithelium. In contrast, antibodies against both spike and nucleocapsid revealed the frequent (70%) infection of bronchial cartilage chondrocytes and para‐bronchial gland epithelial cells. In a few patients (19%), we also detected positivity in vascular pericytes and endothelial cells. Quantitative RT‐PCR amplification in tissue lysates confirmed the presence of viral RNA. Together, these findings indicate that SARS‐CoV‐2 infection can persist significantly longer than suggested by standard PCR‐negative tests, with specific infection of specific cell types in the lung. Whether these persistently infected cells also play a pathogenic role in long COVID remains to be addressed. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2RNA, ViralEndothelial CellsPost-Acute COVID-19 Syndrome

Stichwörter der Autor:innen

COVID-19SARS-CoV-2cartilagenucleocapsidparabronchial glandspost-mortem analysisspikesyncytia

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
  • International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
  • School of Cardiovascular Medicine & Sciences, King's College London, British Heart Foundation Centre of Research Excellence, London, UK.

ORCID-Profile: Mauro Giacca

Förderung

  • European Research Council
  • British Heart Foundation
  • KCL

Zitieren

APA

Bussani, R., Zentilin, L., Correa, R., Colliva, A., Silvestri, F., Zacchigna, S., Collesi, C., & Giacca, M. (2023). Persistent SARS‐CoV ‐2 infection in patients seemingly recovered from COVID ‐19. The Journal of Pathology. https://doi.org/10.1002/path.6035

Vancouver

Bussani R, Zentilin L, Correa R, Colliva A, Silvestri F, Zacchigna S, et al. Persistent SARS‐CoV ‐2 infection in patients seemingly recovered from COVID ‐19. The Journal of Pathology. 2023. doi:10.1002/path.6035

BibTeX
@article{Bussani2023,
  author = {Bussani, Rossana and Zentilin, Lorena and Correa, Ricardo and Colliva, Andrea and Silvestri, Furio and Zacchigna, Serena and Collesi, Chiara and Giacca, Mauro},
  title = {Persistent SARS‐CoV ‐2 infection in patients seemingly recovered from COVID ‐19},
  journal = {The Journal of Pathology},
  year = {2023},
  doi = {10.1002/path.6035}
}
Kostenlos starten →